Sporadic colorectal carcinomas with low-level microsatellite instability in Korea: Do they form a distinct subgroup with distinguished clinicopathological features?

Journal of Surgical Oncology

Volumn 99, Issue 6, 2009, Pages 351-355

  Kim, Young Ho ^a   Min, Byung Hoon ^a   Hyo, Kyung Choi ^a   Sue, Jin Kim ^a   Kim, Kyoung Mee ^a   Jin, Yong Kim ^a   Dong, Kyung Chang ^a   Hee, Jung Son ^a   Rhee, Poong Lyul ^a   Kim, Jae J ^a   Jong, Chul Rhee ^a   Chun, Ho Kyung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COLON ADENOCARCINOMA; COLON RESECTION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; KOREA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; MUCINOUS CARCINOMA; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; CANCER STAGING; COLORECTAL TUMOR; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; KOREA; LYMPHATIC METASTASIS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; NEOPLASM STAGING; YOUNG ADULT;

EID: 65449130835     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21239     Document Type: Article

References (28)

1. Boland CR, Thibodeau SN, Hamilton SR, et al.: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-5257.
2. Umar A, Boland CR, Terdiman JP, et al.: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261-268.
3. Soreide K, Janssen EA, Soiland H, et al.: Microsatellite instability in colorectal cancer. Br J Surg 2006;93:395-406.
4. Peltomaki P: Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003;21:1174-1179. (Pubitemid 46594150)
5. Tomlinson I, Halford S, Aaltonen L, et al.: Does MSI-low exist? J Pathol 2002;197:6-13.
6. Thibodeau SN, French AJ, Cunningham JM, et al.: Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 1998;58:1713-1718.
7. Kambara T, Matsubara N, Nakagawa H, et al.: High frequency of low-level microsatellite instability in early colorectal cancer. Cancer Res 2001;61:7743-7746.
8. Halford S, Sasieni P, Rowan A, et al.: Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait. Cancer Res 2002;62:53-57.
9. Laiho P, Launonen V, Lahermo P, et al.: Low-level microsatellite instability in most colorectal carcinomas. Cancer Res 2002;62:1166-1170.
10. Halling KC, French AJ, McDonnell SK, et al.: Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst 1999;91:1295-1303.
11. Jass JR, Biden KG, Cummings MC, et al.: Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol 1999;52:455-460.
12. Whitehall VL, Walsh MD, Young J, et al.: Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 2001;61:827-830.
13. Biden KG, Simms LA, Cummings M, et al.: Expression of Bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instability. Oncogene 1999;18:1245-1249.
14. Mori Y, Selaru FM, Sato F, et al.: The impact of microsatellite instability on the molecular phenotype of colorectal tumors. Cancer Res 2003;63:4577-4582.
15. Kohonen-Corish MR, Daniel JJ, Chan C, et al.: Low microsatellite instability is associated with poor prognosis in stage C colon cancer. J Clin Oncol 2005;23:2318-2324.
16. Wright CM, Dent OF, Newland RC, et al.: Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma. Gut 2005;54:103-108.
17. Rudzki Z, Zazula M, Okon K, et al.: Low-level microsatellite instability colorectal carcinomas: Do they really belong to a "gray zone" between high-level microsatellite instability and microsatellite-stable cancers? Int J Colorectal Dis 2003;18:216-221.
18. Oliart S, Martinez-Santos C, Moreno-Azcoita M, et al.: Do MSI-L sporadic colorectal tumors developthrough "mild mutatorpathway"? Am J Clin Oncol 2006;29:364-370.
19. American Joint Committee on Cancer. AJCC cancer staging manual. 6th edition. New York: Springer; 2002.
20. Vasen HF, Watson P, Mecklin JP, et al.: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999;116:1453-1456.
21. Hoang JM, Cottu PH, Thuille B, et al.: BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 1997;57:300-303.
22. Cravo M, Lage P, Albuquerque C, et al.: BAT-26 identifies sporadic colorectal cancers with mutator phenotype: A correlative study with clinico-pathological features and mutations in mismatch repair genes. J Pathol 1999;188:252-257.
23. Dietmaier W, Wallinger S, Bocker T, et al.: Diagnostic microsatellite instability: Definition and correlation with mismatch repair protein expression. Cancer Res 1997;57:4749-4756.
24. Hatch SB, Lightfoot HM, Jr., Garwacki CP, et al.: Microsatellite instability testing in colorectal carcinoma: Choice of markers affects sensitivity of detection of mismatch repair-deficient tumors. Clin Cancer Res 2005;11:2180-2187.
25. Shen L, Catalano PJ, Benson AB III, et al.: Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy. Clin Cancer Res 2007;13:6093-6098.
26. Van Rijnsoever M, Elsaleh H, Joseph D, et al.: CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer. Clin Cancer Res 2003;9:2898-2903.
27. Issa JP: Methylation and prognosis: Of molecular clocks and hypermethylator phenotypes. Clin Cancer Res 2003;9:2879-2881. (Pubitemid 36993243)
28. Valentini AM, Armentano R, Pirrelli M, et al.: Chemotherapeutic agents for colorectal cancer with a defective mismatch repair system: The state of the art. Cancer Treat Rev 2006;32:607-618.